
Alert: Rating Downgrade (1/10/25)-Neurocrine Biosciences Inc (NASDAQ: NBIX).
Stock Rating Downgrade The Value Trend Rating for Neurocrine Biosciences Inc (NASDAQ: NBIX) weakened in the last week from C to D reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are […]